To test the prognostic value of VISTA+, CD11b+ cells, we assessed the densities of VISTA+ and CD11b+ cells in both tumor as well as stromal compartments of bone marrow tissues, and tested whether cellular densities in either compartment were different between MM patients with low versus high OS (n = 22, median cut-off, Figure 4). Here, ITGAM is linked to neoplasm.